Josh Dube
About Josh Dube
Josh Dube is a Senior Health Economist at the Pan Canadian Pharmaceutical Alliance, with a background in health technology assessment and drug pricing negotiations. He has held various roles in health economics and research across multiple organizations in Canada, demonstrating a commitment to enhancing patient access to innovative medicines.
Current Role at Health | Santé
Josh Dube serves as a Senior Health Economist at the Pan Canadian Pharmaceutical Alliance (pCPA). He has been in this role since 2022, contributing to the organization's efforts in health economics and pharmaceutical policy. His work focuses on optimizing patient access to medications through effective health technology assessments and drug pricing strategies.
Previous Experience in Health Economics
Before his current position, Josh Dube worked at CADTH as the Lead in Health Economics for four months in 2021. He also held a role as a Health Economist at the Ontario Ministry of Health for four months in the same year. His experience includes significant involvement in health technology assessments and drug pricing negotiations.
Educational Background in Biotechnology and Microbiology
Josh Dube obtained a Master's degree in Biotechnology from the University of Toronto Mississauga, completing his studies from 2018 to 2020. Prior to this, he earned a Bachelor of Medical Science in Microbiology and Immunology with Pathology from Western University, where he studied from 2012 to 2018. His educational background supports his expertise in health economics and technology assessments.
Research and Development Experience
Josh Dube has a diverse background in research and development. He worked as a Research Scientist at St Joseph Hospital from 2017 to 2018 and as a Research Associate at Cornerstone Research Group Inc. in 2019. His earlier roles include positions at EVERSANA as an Associate Project Manager and Project Manager, where he focused on project management in the pharmaceutical sector.
Professional Skills and Expertise
Josh Dube possesses expertise in health technology assessment (HTA) submissions and drug pricing negotiations. His professional experience spans various roles in health economics, research, and project management, reflecting a strong commitment to enhancing patient access to innovative medicines.